Expanded Natural Killer Cells Following Haploidentical HSCT for AML/MDS

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Expanded Natural Killer Cells Following Haploidentical HSCT for AML/MDS	Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, bone marrow disorder, hematologic disorder, leukemia, myelodysplastic syndrome, myeloid leukemia, neoplasm	Recruiting	Phase 1 / Phase 2	2025-12-04		NCT03300492

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
University Hospital, Basel, Switzerland	243

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
University Hospital Basel	Basel	Switzerland	100

Clinical trials